CollPlant Biotechnologies (CLGN) Stock Fundamentals

CollPlant Biotechnologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yehiel Tal, with a market cap of $5.5M.

Market cap

$5.48M-83.4%

We’re still putting together CollPlant Biotechnologies’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move CollPlant Biotechnologies up the queue, and we’ll analyze its filings next.

Earnings

Q1 2026 report

May 29, 2026

Revenue$73.0KMiss by $387.0K EPS-$0.23Beat by $0.01

Read the full report

Next report

Aug 31, 2026 (In 2 days)

Revenue estimate$480.0K

EPS estimate-$0.24

Profile

CountryIsrael

Listed2021

Employees73.0

CEOYehiel Tal

SectorHealthcare

IndustryBiotechnology

Websitecollplant.com

FilingsSEC EDGAR